Skip to content

AETERNUM HEALTH, INC.: 10-Q filed 2019-12-20

What AETERNUM HEALTH, INC. reported in its quarterly report filed 2019-12-20 (fiscal Q2 2019): 22 published measures, 65 facts as tagged in accession 0001391609-19-000209.

This filing

Form
10-Q (quarterly report)
Filed
2019-12-20
Fiscal period
fiscal Q2 2019
Accession
0001391609-19-000209 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AETERNUM HEALTH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-08-3140USD
At 2019-02-28295USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-08-312,386,051USD
At 2019-02-282,368,232USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-08-31-2,386,011USD
At 2019-02-28-2,367,937USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-08-3140USD
At 2019-02-28295USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-06-01 to 2019-08-31-10,912USD92
2019-03-01 to 2019-08-31-18,075USD184
2018-06-01 to 2018-08-31-17,984USD92
2018-03-01 to 2018-08-31-36,634USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-03-01 to 2019-08-31-19,260USD184
2018-03-01 to 2018-08-31-31,798USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-06-01 to 2019-08-310USD92
2019-03-01 to 2019-08-310USD184
2018-06-01 to 2018-08-310USD92
2018-03-01 to 2018-08-310USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-03-01 to 2019-08-3119,005USD184
2018-03-01 to 2018-08-3131,750USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-08-31-5,069,994USD
At 2019-02-28-5,051,920USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2019-06-01 to 2019-08-313,512,527shares92
2019-03-01 to 2019-08-313,512,527shares184
2018-06-01 to 2018-08-313,512,527shares92
2018-03-01 to 2018-08-313,512,527shares184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2019-06-01 to 2019-08-313,512,527shares92
2019-03-01 to 2019-08-313,512,527shares184
2018-06-01 to 2018-08-313,512,527shares92
2018-03-01 to 2018-08-313,512,527shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2019-06-01 to 2019-08-31-0.01USD/shares92
2019-03-01 to 2019-08-31-0.01USD/shares184
2018-06-01 to 2018-08-31-0.01USD/shares92
2018-03-01 to 2018-08-31-0.01USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2019-06-01 to 2019-08-31-0.01USD/shares92
2019-03-01 to 2019-08-31-0.01USD/shares184
2018-06-01 to 2018-08-31-0.01USD/shares92
2018-03-01 to 2018-08-31-0.01USD/shares184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-06-01 to 2019-08-31-10,912USD92
2019-03-01 to 2019-08-31-18,075USD184
2018-06-01 to 2018-08-31-17,984USD92
2018-03-01 to 2018-08-31-36,459USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-08-3140USD
At 2019-02-28295USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-06-01 to 2019-08-310USD92
2019-03-01 to 2019-08-310USD184
2018-06-01 to 2018-08-310USD92
2018-03-01 to 2018-08-31175USD184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-08-312,386,051USD
At 2019-02-282,368,232USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-08-312,679,855USD
At 2019-02-282,679,855USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2019-06-01 to 2019-08-31-10,912USD92
2019-03-01 to 2019-08-31-18,075USD184
2018-06-01 to 2018-08-31-17,984USD92
2018-03-01 to 2018-08-31-36,634USD184

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2019-03-01 to 2019-08-31-18,075USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-06-01 to 2019-08-310USD92
2019-03-01 to 2019-08-310USD184
2018-06-01 to 2018-08-310USD92
2018-03-01 to 2018-08-31-175USD184

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2019-06-01 to 2019-08-310USD92
2019-03-01 to 2019-08-310USD184
2018-06-01 to 2018-08-310USD92
2018-03-01 to 2018-08-310USD184

Inspect the source

Entity
AETERNUM HEALTH, INC. / CIK 0000764630
Captured
2026-09-19T15:02:38.824Z
SEC response SHA-256
6c9d70d4b82a4edc5f4de8082c897762179c66ba1d127e497154b6262edf21b8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000764630.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))